How COVID-19 will affect the development of synthetic biology?

The Bill & Melinda Gates Foundation and the National Institutes of Health have invested in synthetic biology in the hope of designing vaccines for COVID-19. A vaccine developed through synthetic biology would be highly scalable to millions and would work without the need for refrigeration, which is ideal for global applications.

Several companies have been developing experimental vaccines containing synthetic strands of RNA or DNA, one of which INO-4800 is currently in phase I human clinical trials and works by delivering synthetic genes into a person's cells.

Distributed Bio researchers are collaborating with WHO and the U.S. military to create pseudovirionic versions of the disease (which pose less risk) to help discover antibodies.

Thanks for reading, have a nice day <3



Reply

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud